CS logo
small CS logo
Onyx Clinical Research

Flint, Michigan, United States

About Onyx Clinical Research


"Onyx Clinical Research is devoted to progressing the future of medicine. Established in Michigan, we believe the best medical treatments should be available for patients. Thus we are conducting clinical trials on novel medicines and treatments."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Onyx Clinical Research


During the past decade, Onyx Clinical Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Onyx Clinical Research" #1 sponsor was "Pfizer" with 2 trials, followed by "Evofem Inc." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Kissei Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

Clinical Trials Conditions at Onyx Clinical Research


According to Clinical.Site data, the most researched conditions in "Onyx Clinical Research" are "Endometriosis" (2 trials), "Alzheimer Disease" (1 trials), "Atopic Dermatitis" (1 trials), "Chlamydia" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Onyx Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Onyx Clinical Research


Most popular intervention types in "Onyx Clinical Research" are "Drug" (7 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Abrocitinib 200 mg" (2 trials) and "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Onyx Clinical Research


The vast majority of trials in "Onyx Clinical Research" are 4 trials for "Female" genders and 3 trials for "All" genders.

Clinical Trials Status at Onyx Clinical Research


Currently, there are NaN active trials in "Onyx Clinical Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Onyx Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Onyx Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".